Michael A. Borofsky

Michael A. Borofsky

Rheumatology

2760 Century Blvd
Ste 3
Wyomissing, PA 19610

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.

Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.

Journal: The Journal of rheumatology

Published: September 19, 2017

Showing 1-1 of 1

Last Updated: 09/26/2026